Buscar
Biomx Inc
PHGEAñadir a la lista de seguimiento
0.681USD
-0.039-5.42%
Cierre 09-10 16:00（ET）
23.42MCap. mercado
PérdidaP/E TTM
Más Datos de Biomx Inc Compañía
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Perfil de Biomx Inc
Símbolo de cotizaciónPHGE
Nombre de la empresaBiomx Inc
Fecha de salida a bolsaDec 18, 2018
Director ejecutivoSolomon (Jonathan Eitan)
Número de empleados52
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 18
Dirección22 Einstein St.
CiudadNESS-ZIONA
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísIsrael
Código postal7414003
Teléfono972723942377
Sitio Webhttps://www.biomx.com/
Símbolo de cotizaciónPHGE
Fecha de salida a bolsaDec 18, 2018
Director ejecutivoSolomon (Jonathan Eitan)
Ejecutivos de Biomx Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Mr. Ben Cohen
Mr. Ben Cohen
IR Contact Officer
IR Contact Officer
--
--
Mr. Shaked Ran
Mr. Shaked Ran
Independent Director
Independent Director
--
--
Mr. David Rokach
Mr. David Rokach
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
--
--
Mr. Amir Shalom
Mr. Amir Shalom
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Biomx Inc?
Los cinco principales accionistas de Biomx Inc son: Mr. Reuven Yeganeh
¿Cuántas instituciones poseen acciones de Biomx Inc (PHGE)?
A fecha de 2026Q1, 36 instituciones poseen acciones de Biomx Inc, con un valor de mercado combinado de aproximadamente 319.22K, lo que representa el 6.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -512775.00.